IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
A Phase I Study of the Effects of APF530 Exposure, Granisetron and Moxifloxacin
This study has been completed.
Sponsor:
Heron Therapeutics
Information provided by (Responsible Party):
Heron Therapeutics
ClinicalTrials.gov Identifier:
NCT01416259
First received: August 10, 2011
Last updated: August 3, 2015
Last verified: August 2015
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | October 2011 |
| Primary Completion Date: | October 2011 (Final data collection date for primary outcome measure) |